Pictet Asset Management
CGON icon

Pictet Asset Management’s CG Oncology CGON Stock Holding History

Pictet Asset Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1M Sell
255,059
-142,946
-36% -$9.34M 0.02% 554
2026
Q1 		$26.9M Sell
398,005
-951,522
-71% -$53.9M 0.03% 435
2025
Q4 		$56M Buy
1,349,527
+30,960
+2% +$1.28M 0.05% 309
2025
Q3 		$53.1M Sell
1,318,567
-35,816
-3% -$1.04M 0.05% 314
2025
Q2 		$35.2M Buy
1,354,383
+606,554
+81% +$14.6M 0.04% 382
2025
Q1 		$18.3M Buy
747,829
+73,222
+11% +$2.06M 0.02% 518
2024
Q4 		$19.3M Buy
+674,607
New +$23.1M 0.02% 512

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management's CGON Position: Q2 2026 in Review

Pictet Asset Management reduced its CG Oncology (CGON) stake by 36% in Q2 2026, selling an estimated $9.34M and leaving 255,059 shares worth $18.1M. The position accounts for 0.02% of the portfolio, ranked #554.

Pictet Asset Management first reported a position in CGON in Q4 2024 and has held it in 7 quarters since. The position peaked at $56M in Q4 2025. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Pictet Asset Management held 255,059 shares of CG Oncology worth $18.1M as of Q2 2026.
  • Pictet Asset Management sold 142,946 CG Oncology shares in Q2 2026, an estimated $9.34M.
  • CG Oncology made up 0.02% of Pictet Asset Management's portfolio in Q2 2026, its #554 holding.
  • Pictet Asset Management first reported a position in CG Oncology in Q4 2024 and has held it in 7 quarters since.
  • Pictet Asset Management's CG Oncology position peaked at $56M in Q4 2025.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.